Wednesday, July 29, 2020 Daily Archives

ABC news: Lonza to scale-up ophthalmic therapy for Kodiak

by

CDMO Lonza will use its global network, including a dedicated facility in Switzerland, to produce Kodiak Sciences’ antibody biopolymer conjugate (ABC) KSI-301. KSI-301 is an anti-VEGF biopolymer conjugate being developed by Kodiak Sciences for various ophthalmic retinal diseases. The candidate is in Phase II/III studies for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME), and as the firm looks to commercialization it has inked a deal for manufacturing scale-up with Lonza. The contract development and manufacturing organization…

July 29, 2020

Pfizer blasts Trump’s pricing plans, threatens to pull US investments

by

CEO Albert Bourla says Pfizer will rethink plans to invest in US R&D and manufacturing after lambasting four executive orders aimed at reducing drug prices unveiled last week. Like most areas of society, Big Pharma’s relationship with US President Donald Trump has been tumultuous. Initial fears of a clampdown on drug pricing through promises to ‘drain the swamp’ were abated through Trump cozying up with the sector once in office. And reforms passed by Congress in 2017 through the ‘Tax Cuts…

July 29, 2020